Budd-Chiari Syndrome in a Patient Heterozygous for both Factor V Leiden and the G20210A Mutation on the Prothrombin Gene

• References

• 1 Shill M, Henderson JM, Tavill AS. The Budd-Chiari syndrome revisited. The Gastroentrologist 1994; 2: 27-37.
• 2 Mohanty Dipika, Shetty S, Narayanan TS, Abraham P. Factor V Leiden mutation and Budd-Chiari syndrome. Blood 1998; 92: 1838-9.
• 3 Mahmoud AE, Elias E, Beauchamp N, Wilde JT. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut 1997; 40: 798-800.
• 4 Bucciarelli P, Franchi F, Alatri A, Bettini P, Moia M. Budd-Chiari syndrome in a patient heterozygous for the G20210A mutation of the prothrombin gene. Thromb Haemost 1998; 79: 445-6.
• 5 Gürgey A, Mesci L. The prevalence of factor V Leiden mutation in Turkish population. Turk J Pediatr 1997; 39: 37-9.
• 6 Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma DP. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85: 1504-8.
• 7 Simioni P, Prandoni P, Lensing AW, Scudeller A, Sardella C, Prins MH, Villalta S, Dazzi F, Girolami A. The risk of recurrent venous thromboembolism in patients with an Arg 506→Gln mutation in the gene for factor V (factor V Leiden). N Eng J Med 1997; 336: 399-403.
• 8 Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’ untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
• 9 Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral vein thrombosis in carriers of thrombin gene mutation and in users of oral contraceptives. N Eng J Med 1998; 338: 1793-7.